Public annual accounts

Camilex Mngt financials

Name: Camilex Mngt financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Camilex Mngt, with comparable measures and links to available source documents.

Company overview

Registry number

1004904558

Fiscal coverage

2025–2026

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Camilex Mngt

2026 versus 2025

Operating line: €152,571
EBITDA: €152,571
Total assets: €297,603
Equity: €282,677

EBITDA margin +100% · Equity ratio +95%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202631 Mar 2026	€152,571	€152,571	€297,603	€282,677	-
202531 Mar 2025	€145,838	€145,838	€174,050	€164,756	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2025 to 2026 · Method family

Open report